Importer of Controlled Substances Application: Cerilliant Corporation, 40875-40877 [2021-16136]
Download as PDF
<![CDATA[
40875
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
Drug Enforcement Administration
[Docket No. DEA–868]
Importer of Controlled Substances
Application: Cerilliant Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cerilliant Corporation has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 30, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 30, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
DATES:
DEPARTMENT OF JUSTICE
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on June 23, 2021,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................
Cathinone ................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Fenethylline .............................................................................................................................................................
Methaqualone ..........................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .........................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .......
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ....................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ...........................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..................................
Lysergic acid diethylamide ......................................................................................................................................
2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .......................................................................................
Marihuana ................................................................................................................................................................
Parahexyl .................................................................................................................................................................
Mescaline ................................................................................................................................................................
2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ..................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\29JYN1.SGM
29JYN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
2565
6250
7008
7011
7012
7019
7023
7024
7031
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7374
7381
7385
7390
7391
7392
7395
7396
7398
7400
7401
7402
7404
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
40876
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
Drug code
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Bufotenine ...............................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin ................................................................................................................................................................
Psilocyn ...................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
N-Benzylpiperazine .................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .............................................................................................
2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ..........................................................................................
2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) .............................................................................................
2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) ..........................................................................................................
2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .................................................................................................
2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ...........................................................................................
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ............................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .....................................................................................
2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ............................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................
25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................
25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................
Desomorphine .........................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................
Codeine methylbromide ...........................................................................................................................................
Heroin ......................................................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................
Normorphine ............................................................................................................................................................
Pholcodine ...............................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................
AH–7921 (3,4-dichloro-N-[(1- dimethylamino)cyclohexylmethyl]benzamide)) ........................................................
Acetylmethadol ........................................................................................................................................................
Allylprodine ..............................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................
Alphameprodine ......................................................................................................................................................
Alphamethadol .........................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................
Betameprodine ........................................................................................................................................................
Betamethadol ..........................................................................................................................................................
Betaprodine .............................................................................................................................................................
Dextromoramide ......................................................................................................................................................
Dipipanone ..............................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................
Noracymethadol ......................................................................................................................................................
Norlevorphanol ........................................................................................................................................................
Normethadone .........................................................................................................................................................
Racemoramide ........................................................................................................................................................
Trimeperidine ...........................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................
Tilidine .....................................................................................................................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................
3-Methylthiofentanyl ................................................................................................................................................
Thiofentanyl .............................................................................................................................................................
Fentanyl related-substances as defined in 21 CFR 1308.11(h) .............................................................................
Methamphetamine ...................................................................................................................................................
Methylphenidate ......................................................................................................................................................
Amobarbital .............................................................................................................................................................
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
E:\FR\FM\29JYN1.SGM
29JYN1
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7455
7458
7470
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9055
9056
9070
9200
9307
9313
9314
9547
9551
9601
9602
9603
9604
9605
9607
9608
9609
9611
9613
9622
9627
9633
9634
9635
9645
9646
9661
9750
9812
9813
9814
9815
9830
9831
9832
9833
9835
9850
1105
1724
2125
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
40877
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
Controlled substance
Drug code
Pentobarbital ...........................................................................................................................................................
Secobarbital .............................................................................................................................................................
Glutethimide ............................................................................................................................................................
Nabilone ..................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................
Phencyclidine ..........................................................................................................................................................
Phenylacetone .........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................
Alphaprodine ...........................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Levomethorphan ......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Racemethorphan .....................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ...............................................................................................................................................................
Tapentadol ...............................................................................................................................................................
The company plans to import the
listed controlled substances for the
manufacturing of analytical reference
standards and distribution to their
research and forensic customers.
Approval of permit application will
occur only when the registrant’s activity
is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of Food
and Drug Administration-approved or
non-approved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–16136 Filed 7–28–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–871]
Importer of Controlled Substances
Application: Purisys, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC. has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 30, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 30, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 29, 2021, Purisys,
LLC., 1550 Olympic Drive, Athens,
Georgia 3601–1602, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
Controlled substance
Opium, raw .....................
Opium, powdered ...........
Opium, granulated ..........
I
Drug
code
Schedule
9600
9639
9640
II
II
II
I
The company plans to import Opium,
raw (9600), Opium, powered (9639) and
Opium, granulated (9640) to
manufacture Active Pharmaceutical
Ingredient (API) only for distribution to
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
2270
2315
2550
7379
7460
7471
8501
8603
9010
9120
9180
9190
9210
9220
9230
9273
9648
9668
9732
9737
9739
9740
9743
9780
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
its customers. No other activity for these
drug codes is authorized for this
registration. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of the
Food and Drug Administrationapproved or non-approved finished
dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–16142 Filed 7–28–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Employment and Training
Administration
Request for Nominations for
Membership on the Native American
Employment and Training Council
Employment and Training
Administration, Labor.
AGENCY:
ACTION:
Request for nominations.
The Department of Labor
(DOL) invites interested parties to
submit nominations for individuals to
serve on the Native American
Employment and Training Council
(NAETC) and announces the procedures
for those nominations. When submitting
nomination materials, please indicate
the Region or Discipline for which the
nominee would like to be considered.
Information regarding the NAETC can
SUMMARY:
E:\FR\FM\29JYN1.SGM
29JYN1
]]>Agencies
[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40875-40877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16136]
[[Page 40875]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-868]
Importer of Controlled Substances Application: Cerilliant
Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cerilliant Corporation has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 30, 2021.
Such persons may also file a written request for a hearing on the
application on or before August 30, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on June 23, 2021, Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas 78665-2402, applied to be registered
as an importer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3- 1233 I
FMC).
Cathinone........................ 1235 I
Methcathinone.................... 1237 I
4-Fluoro-N-methylcathinone (4- 1238 I
FMC).
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC) 1249 I
Naphyrone........................ 1258 I
N-Ethylamphetamine............... 1475 I
N,N-Dimethylamphetamine.......... 1480 I
Fenethylline..................... 1503 I
Methaqualone..................... 2565 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl- 7012 I
1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone).
AB-CHMINACA (N-(1-amino-3-methyl- 7031 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
ADB-PINACA (N-(1-amino-3,3- 7035 I
dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-
carboxamide).
APINACA and AKB48 (N-(1- 7048 I
Adamantyl)-1-pentyl-1H-indazole-
3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole).
JWH-018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4- 7200 I
Morpholinyl)ethyl]-3-(1-
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
Alpha-ethyltryptamine............ 7249 I
Ibogaine......................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)- 7297 I
2-[(1R,3S)-3-hydroxycyclohexyl-
phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide....... 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana........................ 7360 I
Parahexyl........................ 7374 I
Mescaline........................ 7381 I
2C-T-2 (2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine ).
3,4,5-Trimethoxyamphetamine...... 7390 .....................
4-Bromo-2,5-dimethoxyamphetamine. 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5-dimethoxyamphetamine 7395 I
2,5-Dimethoxyamphetamine......... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
3,4-Methylenedioxyamphetamine.... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
[[Page 40876]]
3,4-Methylenedioxymethamphetamine 7405 I
4-Methoxyamphetamine............. 7411 I
5-Methoxy-N-N-dimethyltryptamine. 7431 I
Alpha-methyltryptamine........... 7432 I
Bufotenine....................... 7433 I
Diethyltryptamine................ 7434 I
Dimethyltryptamine............... 7435 I
Psilocybin....................... 7437 I
Psilocyn......................... 7438 I
5-Methoxy-N,N- 7439 I
diisopropyltryptamine.
N-Ethyl-1-phenylcyclohexylamine.. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine 7458 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine............... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4- 7508 I
methylphenyl) ethanamine).
2C-E (2-(2,5-Dimethoxy-4- 7509 I
ethylphenyl) ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine).
2C-I 2-(4-iodo-2,5- 7518 I
dimethoxyphenyl) ethanamine).
2C-C 2-(4-Chloro-2,5- 7519 I
dimethoxyphenyl) ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro- 7521 I
phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
25B-NBOMe (2-(4-bromo-2,5- 7536 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5- 7537 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5- 7538 I
dimethoxyphenyl)-N-(2-
methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone......................... 7541 I
Pentylone........................ 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Desomorphine..................... 9055 I
Etorphine (except HCl)........... 9056 I
Codeine methylbromide............ 9070 I
Heroin........................... 9200 I
Morphine-N-oxide................. 9307 I
Normorphine...................... 9313 I
Pholcodine....................... 9314 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]b
enzamide)).
Acetylmethadol................... 9601 I
Allylprodine..................... 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine................... 9604 I
Alphamethadol.................... 9605 I
Betacetylmethadol................ 9607 I
Betameprodine.................... 9608 I
Betamethadol..................... 9609 I
Betaprodine...................... 9611 I
Dextromoramide................... 9613 I
Dipipanone....................... 9622 I
Hydroxypethidine................. 9627 I
Noracymethadol................... 9633 I
Norlevorphanol................... 9634 I
Normethadone..................... 9635 I
Racemoramide..................... 9645 I
Trimeperidine.................... 9646 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
Tilidine......................... 9750 I
Para-Fluorofentanyl.............. 9812 I
3-Methylfentanyl................. 9813 I
Alpha-methylfentanyl............. 9814 I
Acetyl-alpha-methylfentanyl...... 9815 I
Beta-hydroxyfentanyl............. 9830 I
Beta-hydroxy-3-methylfentanyl.... 9831 I
Alpha-methylthiofentanyl......... 9832 I
3-Methylthiofentanyl............. 9833 I
Thiofentanyl..................... 9835 I
Fentanyl related-substances as 9850 I
defined in 21 CFR 1308.11(h).
Methamphetamine.................. 1105 II
Methylphenidate.................. 1724 II
Amobarbital...................... 2125 II
[[Page 40877]]
Pentobarbital.................... 2270 II
Secobarbital..................... 2315 II
Glutethimide..................... 2550 II
Nabilone......................... 7379 II
1-Phenylcyclohexylamine.......... 7460 II
Phencyclidine.................... 7471 II
Phenylacetone.................... 8501 II
1- 8603 II
Piperidinocyclohexanecarbonitril
e.
Alphaprodine..................... 9010 II
Dihydrocodeine................... 9120 II
Ecgonine......................... 9180 II
Ethylmorphine.................... 9190 II
Levomethorphan................... 9210 II
Levorphanol...................... 9220 II
Meperidine....................... 9230 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Levo-alphacetylmethadol.......... 9648 II
Noroxymorphone................... 9668 II
Racemethorphan................... 9732 II
Alfentanil....................... 9737 II
Remifentanil..................... 9739 II
Sufentanil....................... 9740 II
Carfentanil...................... 9743 II
Tapentadol....................... 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
the manufacturing of analytical reference standards and distribution to
their research and forensic customers. Approval of permit application
will occur only when the registrant's activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend
to the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-16136 Filed 7-28-21; 8:45 am]
BILLING CODE P
